title: [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study].
abstract: Ependymomas are rare intracranial tumors observed in adults. Prognostic factors as well as proper therapeutic management remain controversial. We report a retrospective study of 121 cases intracranial ependymomas diagnosed between 1990 and 2004 in adult patients. Mean age was 46 years with a 1/1 sex-ratio. Supratentorial and infratentorial localization was noted for 41 (33.9%) and 80 (66.1%) patients respectively. Total gross resection was achieved for 62.8% of tumors. WHO staging was grade II for 72.7% and III for 27.3%. Recurrence developed in 41 (33.9%) patients. Median follow-up was 70 months. The 5-year and 10-year overall survivals were 85 and 76% respectively; the respective progression-free survivals were 64 and 43%. At univariate analysis, age, KPS, localization, extent of surgery and histological grade were correlated with overall survival. At multivariate analysis age, location, histological grade and extent of surgery contributed most to prediction of overall survival. Concerning progression-free survival, univariate analysis found age, KPS, localization, extent of surgery, complementary treatment and histological grade to be correlated with recurrence. Multivariate analysis retained extent of surgery, histological grade and complementary treatment as the most important predictors of progression-free survival. This study demonstrated that extent of surgery and tumor grade are the two main prognostic factors in adult intracranial ependymomas with respect to overall and progression-free survival. Furthermore, our data suggest that postoperative radiotherapy significantly increases progression-free survival in patients with incompletely resected grade II tumors.
authors.affiliation: Service de neurochirurgie du Professeur-Grisoli, hôpital de La Timone, 264, rue Saint-Pierre, 13385 Marseille cedex 05, France. philippe.metellus@mail.ap-hm.fr
authors.forename: P
authors.initials: P
authors.lastname: Metellus
authors.forename: M
authors.initials: M
authors.lastname: Barrie
authors.forename: D
authors.initials: D
authors.lastname: Figarella-Branger
authors.forename: O
authors.initials: O
authors.lastname: Chinot
authors.forename: R
authors.initials: R
authors.lastname: Giorgi
authors.forename: A
authors.initials: A
authors.lastname: Jouvet
authors.forename: J
authors.initials: J
authors.lastname: Guyotat
mesh_terms: D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D004806:Ependymoma / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000453:epidemiology; D019635:Neurosurgical Procedures / Q000379:methods*; D012189:Retrospective Studies